CPT code 83993 – Fecal calprotectin test

Key takeaways

CPT code 83993 reports one quantitative calprotectin measurement on a stool specimen, run by immunoassay. Blood or serum calprotectin assays do not map to it.

K50.x (Crohn’s disease) and K51.x (ulcerative colitis) are the best-supported diagnosis pairings. IBS codes (K58.x) draw more payer scrutiny and need the rule-out intent documented.

Medicare’s 2024 Clinical Laboratory Fee Schedule set the national rate for 83993 at $19.63. At that price, reworking a denied claim costs a large share of what the test pays.

Many commercial payers require prior authorization for 83993, while Medicare generally does not. Verify the plan’s rule before the specimen is collected.

Pabau, the practice management platform we build, checks eligibility through Claim.MD and warns staff when a case is missing its prior authorization code.

CPT code 83993: Official descriptor and test overview

CPT code 83993 is the procedure code for a quantitative fecal calprotectin test. Its official American Medical Association (AMA) descriptor is Calprotectin, fecal. The code sits in the Chemistry subsection of the CPT Pathology and Laboratory section, which spans codes 80047-89398.

Calprotectin is a calcium-binding protein that neutrophils release during gastrointestinal (GI) inflammation. When the gut is inflamed, calprotectin levels in stool rise sharply. The lab measures that concentration with an enzyme-linked immunosorbent assay (ELISA) or an equivalent quantitative immunoassay.

What CPT 83993 includes and what it does not cover

CPT code 83993 covers exactly one quantitative calprotectin measurement from a stool specimen. The descriptor is only two words long, so coders often stretch it to tests it does not cover, or miss what it already includes.

What the code includes

• Quantitative fecal calprotectin measured by immunoassay on a stool specimen
• Analysis of a self-collected stool sample at a clinical or reference laboratory
• Laboratory analysis and result reporting
• A medically necessary repeat test on the same date of service, reported with modifier 91. Serial monitoring across separate visits is billed as a new 83993, and a rerun for lab error never takes modifier 91

What the code does not cover

• Blood or serum calprotectin assays, which do not use a fecal specimen and do not map to 83993
• Lactoferrin testing, a separate fecal biomarker billed under its own code
• Occult blood testing (CPT 82272 or 82274), which uses different methods for a different question
• Stool culture (CPT 87045 or 87046) or ova and parasite examinations, which answer an infectious question
• Physician interpretation or consultation, which is coded as a separately documented E/M service when one takes place

Approved clinical indications and ICD-10 codes to pair with CPT 83993

Medicare coverage for CPT 83993 follows Local Coverage Determinations (LCDs) published by Medicare Administrative Contractors (MACs). The ICD-10-CM codes below are the indications payers support most consistently. A diagnosis code the payer does not accept for this test is one of the fastest routes to a denial.

Use the CDC/NCHS ICD-10-CM web tool to find the most specific code for the documented scenario before you pair it with CPT 83993.

Medicare and payer coverage for CPT code 83993

CMS pays CPT 83993 under the Clinical Laboratory Fee Schedule (CLFS). The 2024 Q1 file lists a national payment rate of $19.63 for 83993, effective January 1, 2024. CMS updates the schedule each year, so check the current quarter’s file before relying on any figure.

Medicare coverage is decided at the MAC level through LCDs. No National Coverage Determination (NCD) governs CPT 83993 specifically, so coverage rules vary by jurisdiction. Check your regional MAC for the applicable LCD before billing.

Medical necessity documentation requirements for CPT 83993

Thin documentation is the other common denial trigger for CPT 83993, next to unsupported ICD-10 pairings. The chart note has to show the test is clinically necessary, not ordered as a screening measure.

Use this checklist before submitting a claim. Each item maps to a standard payer audit point and supports medical billing compliance under HIPAA-governed electronic claim standards.

• Ordering diagnosis documented: the chart note names the ICD-10-CM code on the claim as the reason for the test. It is never inferred from earlier encounters
• Symptom duration noted: the note records the relevant GI symptoms (for example, chronic diarrhea, abdominal pain or rectal bleeding) and how long they have lasted
• Differential diagnosis intent stated: the note says the test is ordered to tell IBD from IBS or another non-inflammatory condition
• Prior relevant tests documented: any earlier colonoscopy, imaging or stool culture is referenced, since it supports non-invasive calprotectin monitoring
• Physician order present: a signed order from a physician or qualified provider for the fecal calprotectin test is in the chart
• Repeat-test justification: if 83993 is billed with modifier 91, the note explains why a second measurement was clinically necessary that day

Prior authorization: When it is required and how to obtain it

Medicare does not generally require prior authorization for CPT 83993, but many commercial payers do. Payer policies change frequently, so treat the steps below as a framework rather than a definitive payer list.

Confirm insurance eligibility verification status and prior authorization requirements during the clinical encounter, before the specimen is ordered or collected.

PA submission steps

1. Confirm whether the patient’s specific plan requires PA for CPT 83993, not just the insurer’s general laboratory policy
2. Gather the supporting chart notes, which confirm the GI symptoms, their duration and the differential diagnosis intent
3. Submit the PA request through the payer’s portal or by fax, with the supporting ICD-10 codes and the physician attestation
4. Record the PA reference number in the patient’s chart and in the practice management system before the test is ordered
5. If PA is denied, review the denial reason code and decide whether a peer-to-peer review with the payer’s medical director should come before an appeal

Codes commonly confused with CPT 83993

Gastroenterology coders meet several stool-based and protein-marker codes that are distinct from CPT 83993. The wrong code either overbills, which draws an audit flag, or underbills and leaves payment unclaimed.

The chart below runs the same comparison as a decision. Start from the stool specimen, then ask what the lab measured and how.

The guaiac test that most often gets swapped with this one is 82272, and its descriptor rules out colorectal cancer screening. Use the AAPC Codify CPT lookup to verify descriptors when unsure whether a neighboring code applies. The AMA’s published guidelines take precedence over third-party references.

Top reasons CPT 83993 claims are denied and how to prevent them

Lab tests are often ordered without a same-day E/M visit, so no visit note anchors the medical necessity documentation. For CPT 83993, the same denial categories repeat across practices and payers.

Reviewing denial reason codes against the prevention actions above during claim scrubbing catches most of these issues before they reach the payer.

How to appeal a denied CPT 83993 claim

A denial management workflow for CPT 83993 follows a standard structure. What decides the appeal is the documentation specific to this code.

1. Pull the Explanation of Benefits (EOB) and find the Claim Adjustment Reason Code (CARC) and Remittance Advice Remark Code (RARC) for the denial
2. Match the denial reason to the chart. For a medical necessity denial (CARC 50), compile the physician order, symptom history and ICD-10 coding rationale
3. Identify the LCD for your MAC jurisdiction and cite the covered indications that apply to this patient in the appeal letter
4. Submit the appeal within the payer’s timely-filing window, typically 90 to 180 days from the denial date (confirm it in the payer’s provider manual)
5. If the first-level appeal fails, request a peer-to-peer review with the payer’s medical director before filing a second-level appeal

Billing CPT 83993 in a practice setting: Workflow tips

Most CPT 83993 denials trace back to the order, not the claim. The diagnosis, the prior authorization number and the differential intent are all known when the test is ordered. A workflow that captures them then carries them through to submission.

For medical billing fundamentals applied to lab codes, the key distinction is between in-house and reference laboratory workflows. Each one creates different billing responsibilities.

In-house vs reference lab billing

• In-house lab: the practice performs the assay and bills CPT 83993 directly. It needs CLIA certification for the test’s complexity level, and the claim must carry the performing lab’s NPI and CLIA number.
• Reference lab: the practice collects the specimen and sends it to an outside laboratory, which bills CPT 83993 under its own NPI. The ordering practice bills specimen collection separately where applicable. It never bills 83993 for a test the reference lab performed.

Pre-submission claim scrubbing checklist

• ICD-10-CM codes match the documented clinical indication in the chart note
• The PA number is recorded if the payer requires prior authorization
• The performing laboratory’s NPI and CLIA number are on the claim
• The date of service matches the specimen collection date, not the result date
• Modifier 91 is attached only when a clinically justified repeat test is performed on the same day
• Frequency limits have not been exceeded for this patient and payer

Submitting a clean claim on the first attempt matters most on low-value lab codes like CPT 83993. At a national rate of $19.63, every resubmission takes a large bite out of a small payment.

How claims management software protects CPT 83993 reimbursement

In many gastroenterology practices, eligibility is checked by phone after the visit and the PA number lives in a spreadsheet. The claim is then keyed into a separate billing system, so a missing authorization surfaces only when the denial arrives.

Pabau, the practice management platform we build, keeps the order, the case and the claim on one patient record. Its claims management software runs eligibility checks and sends CMS-1500/837P claims through the Claim.MD clearinghouse. The prior authorization code, dates and sessions sit on the case, and staff get a warning when one is missing.

Practices that switch on Labs can order Quest tests from the patient record, and Labcorp results sync back automatically. Electronic remittance advice posts against the same record. A rejected calprotectin claim shows up the day it happens, not at month-end reconciliation.

Get lab claims right the first time

Pabau checks eligibility through Claim.MD, tracks prior authorization codes on the case, and posts remittances back to the patient record. See how it handles CPT 83993 claims for gastroenterology practices.

Book a demo

Conclusion

At $19.63 a test, CPT 83993 leaves no room for a second submission, so the claim has to be right when the test is ordered. That means a supported diagnosis code, a prior authorization number where the plan needs one, and a note that states the IBD-versus-IBS question. Each of those is known before the specimen leaves the room.

Practices that move those checks to the order step stop paying staff time to rework low-value lab claims. Book a demo to see how Pabau carries the order details through to a clean CPT 83993 claim.

Continue your research

Need to understand how clearinghouse submission works? Medical claims clearinghouse guide explains how claims route from practice to payer and where errors are caught.

Building a denial prevention process from scratch? Revenue cycle management overview covers the end-to-end workflow that keeps lab claims from aging into write-offs.

Looking for the 837P electronic claim format? 837 file guide details the transaction set used for professional claim submissions including CPT 83993.

Frequently asked questions